Vaso Corp
General ticker "VASO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $21.9M
Vaso Corp does not follow the US Stock Market performance with the rate: -40.1%.
Estimated limits based on current volatility of 1.1%: low 0.12$, high 0.12$
Factors to consider:
- US accounted for 97.2% of revenue in the fiscal year ended 2022-12-31
- Current price 41.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.21$, 0.43$]
- 2024-12-30 to 2025-12-30 estimated range: [0.20$, 0.42$]
Financial Metrics affecting the VASO estimates:
- Negative: Non-GAAP EPS, $ of 0.08 <= 0.10
- Positive: 1.03 < Operating profit margin, % of 5.18
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: 2.86 < Return on assets ratio (scaled to [-100,100]) of 5.96
- Positive: Interest expense per share, $ of 0 <= 0
Short-term VASO quotes
Long-term VASO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $75.58MM | $80.02MM | $81.02MM |
| Operating Expenses | $72.76MM | $72.98MM | $76.83MM |
| Operating Income | $2.82MM | $7.03MM | $4.20MM |
| Non-Operating Income | $3.43MM | $0.10MM | $0.71MM |
| Interest Expense | $0.31MM | $0.04MM | $0.00MM |
| R&D Expense | $1.72MM | $0.60MM | $0.76MM |
| Income(Loss) | $6.25MM | $7.13MM | $4.91MM |
| Taxes | $0.15MM | $-4.74MM | $0.10MM |
| Profit(Loss) | $6.10MM | $11.87MM | $4.80MM |
| Stockholders Equity | $11.31MM | $22.88MM | $26.84MM |
| Inventory | $1.15MM | $1.47MM | $1.47MM |
| Assets | $52.36MM | $72.66MM | $75.76MM |
| Operating Cash Flow | $7.82MM | $14.42MM | $5.30MM |
| Capital expenditure | $0.41MM | $0.57MM | $0.73MM |
| Investing Cash Flow | $-0.26MM | $-8.42MM | $-5.66MM |
| Financing Cash Flow | $-8.33MM | $-0.23MM | $-0.13MM |
| Earnings Per Share* | $0.04 | $0.07 | $0.03 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.